Skip to main navigation
Skip to search
Skip to main content
Sort by
Immunology and Microbiology
Human Immunodeficiency Virus 1
100%
Infection
50%
Infectious Disease
47%
Human Immunodeficiency Virus
40%
Prevalence
23%
Drug Resistance
22%
Viral Load
21%
Protease
20%
Proteinase
20%
Virus
19%
Peptides
13%
Blood Plasma
13%
In Vitro
13%
Natural Killer Cell
12%
CXCR4
11%
Hepatitis B Virus
10%
Reverse Transcriptase
9%
Cytotoxic T-Cell
8%
Hepatitis B
8%
Molecular Epidemiology
8%
Integrase
7%
Amino Terminal Sequence
7%
CCR5
7%
Omicron Coronavirus Variant
7%
Peripheral Blood Mononuclear Cell
7%
Breakthrough Infection
6%
Hepatitis C Virus
6%
Heavy Chain
6%
Ribonucleic Acid
6%
Factor H
6%
Replication
5%
Bacteriophage
5%
Chemokine
5%
T-Helper Cell
5%
CD4
5%
Neutralization
5%
Cross-Resistance
5%
Keyphrases
Human Immunodeficiency Virus Type 1 (HIV-1)
22%
Europe
14%
Antiretroviral Therapy
12%
Natural Killer Cells
11%
Protease Inhibitors
8%
Luxembourg
7%
Hepatitis C Virus
7%
European Union
7%
Hepatitis B
7%
Viral Load
7%
Resistance Evaluation
6%
Immunotherapeutics
6%
Multimeric
6%
Highly Active Antiretroviral Therapy (HAART)
6%
Transmitted Drug Resistance
6%
European Economic Area
6%
Resistance-associated Substitutions
5%
Genetic Resistance
5%
Protease
5%
Hepatitis B Virus
5%
Direct-acting Antivirals
5%
HIV Transmission
5%
AIDS/HIV
5%
Hepatitis C
5%
HIV-1 Infection
5%
Living with
5%
Biochemistry, Genetics and Molecular Biology
Human Immunodeficiency Virus 1
35%
Human Immunodeficiency Virus
21%
Protease
9%
Chemokine Receptor
8%
Prevalence
8%
CCR5
6%
CXCR4
6%
Drug Resistance
6%
Co-Receptor
5%
Integrase
5%
N-Terminus
5%
Virus
5%